Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...

WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...

Using AI to assemble real-world COPD data can help to identify specific clinical traits faster and with greater accuracy than traditional data sources This collaboration supports Tessel's drug ...

Researchers at Kent have established a computational protocol that could accelerate the development of more effective ...

Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside ...

The U.S. FDA announced on Tuesday that Amgen (AMGN) and AstraZeneca (AZN) have initiated real-time clinical trials as the agency seeks to launch a pilot program designed to accelerate drug development ...

BASEL, Switzerland--(BUSINESS WIRE)--Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an artificial intelligence application designed to speed ​early ...